$1.3 Billion Sale of Health Care Provider

Served as lead counsel in $1.3 billion sale of health care provider to a strategic buyer.

$114 Million Common Stock Offering for Wholesale Pharma Distributor

Represented a wholesale pharmaceutical distributor as issuer’s counsel in a $114 million underwritten offering of common stock.

Provided Counsel to Pharma Company in Connection with Policies and Procedures

Assisted a major pharmaceutical company with a comprehensive update of policies, including on issues such as interactions with health care providers, sponsorships, educational grants, exhibits and charitable donations, to ensure compliance with federal regulations and industry practice.

Favorable Resolution of Criminal Investigation for Senior Executive of Medical Device Manufacturer

Represented a senior executive at a medical device manufacturer in connection with a criminal investigation involving potential false statements to the U.S. Food and Drug Administration. Resolved without any criminal charges.

Defended Health Care Network from Employment Disability Discrimination Claim

Successfully defended network of assisted living and long-term care facilities from employment disability discrimination claim filed with the Colorado Civil Rights Division and the U.S. Equal Employment Opportunity Commission, resulting in favorable settlement for client and resolution of all claims.

$95 Million Sale of Health Care Financing Company

Counsel to seller for the sale of health care financing company with an enterprise value of approximately $95 million. Sale was to a private-equity backed purchaser and involved a post-closing transition period for state licensing issues.

Structured Multimillion-Dollar, Multi-Year Sponsored Research Program and Joint Venture for Health Care Client

Structured a multimillion-dollar, multi-year sponsored research program and related joint venture between a health care client and a leading research university. Structured budgeting and oversight mechanisms for research funding; structured LLC joint venture (JV) entity and related governance matters; completed licensing agreements and conducted analysis related to JV intellectual property ownership; all enabling future commercialization of intellectual property developed from funded research.

Secured Motion to Dismiss for Hospital in Protected Health Information, Termination Case

Prevailed on a contested motion to dismiss in favor of hospital client. Plaintiff alleged employment termination in part, due to our client’s allegedly inappropriate and unauthorized disclosure of protected health information. Plaintiff asserted a claim alleging breach of fiduciary duty of confidentiality, seeking both economic losses and punitive damages. Relying in part on HIPAA regulations, we filed a motion to dismiss and a motion to strike the punitive damages claims, and after oral argument, the judge granted the motion.

$300 Million Medical Device Industry Acquisition

Represented a public company in the medical device industry acquired in a $300 million transaction.

Delaware Counsel in Specialty Pharma Company Bankruptcy

Delaware counsel to the Official Committee of Unsecured Creditors in the bankruptcy cases for a specialty pharmaceutical company.

Successful Settlement in $400 Million Qui Tam Case

Successfully negotiated a no admission of liability settlement on behalf of a pharmaceutical company in connection with a civil False Claims Act matter investigated by the U.S. Attorney’s Office for the Eastern District of Pennsylvania. The case originated from a qui tam complaint where the government initially sought damages well in excess of $400 million. The case was resolved for approximately 4% of the initial damages assessment, and a Corporate Integrity Agreement was reached with Department of Health and Human Services Office of Inspector General (HHSOIG) that avoided any debarment or exclusion sanctions.

Successful Defense of Medical Practice in FCA Litigation

Successful defense of a medical practice in a federal civil False Claims Act litigation involving a qui tam relator.

Obtained Declination of Prosecution from DOJ for Prominent Medical Doctor

Obtained a declination of prosecution from the Department of Justice on behalf of a prominent medical doctor practicing in the Philadelphia region accused of billing fraud.

Favorable Pre-lawsuit Settlement in Federal False Claims Act Case for Cardiologist

Effectuated a favorable pre-lawsuit settlement with no admission of liability in a federal False Claims Act matter on behalf of a cardiologist in the Philadelphia region.

Successful Outcome for Medical Professional in Connection with Federal False Claims Act Investigation

Defense and non-trial resolution for a medical professional in response to a civil investigative demand issued in connection with a federal False Claims Act investigation.

Advised Biopharma Company on Strategic Investment

Advised a biopharmaceutical company focused on developing new, cost-effective and proprietary treatment options for patients, on its strategic investment into a Scottish-based clinical stage biopharmaceutical company developing novel oxygen carriers and software for use with MRI. 

Led Governor-Ordered 35-Day Investigation of Missouri Veterans Homes After COVID-19 Outbreak

Selected to conduct a rapid, independent, external review of seven Missouri Veterans Homes – as ordered by Gov. Michael Parson – to assess their performance and identify what steps, if any, should be taken to improve their management and prevention of COVID-19. Led a 35-day investigation that considered all relevant information, including interviewing 174 individuals including Missouri Veterans Commission (MVC) staff, Veterans, Veterans’ families and Missouri government officials; implementing a hotline staffed by attorneys for Veterans’ families to voice concerns; reviewing and analyzing hundreds of documents; directing a management and consulting organization serving clients in the long-term care and post-acute care industry, to conduct on-site audits of all seven Homes, following all necessary safety protocols; and issuing early recommendations to the MVC. Compiled and delivered a 53-page summary report and a comprehensive 415-page report, including recommended corrective actions, to state officials.

Sale of Health Care Communications Agency

Advised the shareholders of a specialist health care communications agency in their sale to a FTSE 250 health care advisory, communications, commercial, clinical and packaging services company.

Sake of Life Science Intermediary

Advised the shareholders of the largest provider of IVF programmes in the U.K. on their sale to a private equity buyer.

Advised U.K. Pharma Company in Defamatory Reporting Case

Advised a U.K. pharmaceutical company concerning defamatory reporting in the media about one of its key products.

Advised Overseas Pharma Company in Defense of High Court Proceedings

Advised a leading overseas pharma company in its defense of significant High Court proceedings.

Led Defense Strategy Resulting in Defense Verdict in High-Profile Antitrust Class Action

Represented major, multinational biopharmaceutical company in a massive, high-profile antitrust class action lawsuit in which plaintiffs were seeking in excess of $30 billion in damages. As Global Head of Litigation, led legal defense strategy resulting in a jury defense verdict.

Outside Counsel for $8.5 Billion Life Sciences Company

As outside counsel for an $8.5 billion life sciences company, led a team managing all aspects of IP strategy and execution for a $20 million annual R&D function. Represented the company in multiple M&A transactions over $200 million and advised senior leadership on major strategic decisions around new product launches, commercial partnerships and licenses.

In-House Counsel to Leading Gene Editing Company

As in-house counsel for a leading gene editing company, led a $2 million/year patent preparation and analysis function that built layered protection for the company’s technology platform and therapeutic pipeline, and facilitated major transactions including public stock offerings and partnering of a first-in-class gene editing therapeutic program.

Global Patent Strategy and Execution for Diagnostics Company

As outside counsel for a venture-backed diagnostics company, took on an existing patent estate and developed a multi-pronged protection strategy for a first-in-class clinical microbiology lab system along with key messages for leadership and investors; drove successful U.S. and foreign prosecution to obtain multiple grants offering diversified claim protection ahead of launch; and filed roughly 30 new patent families over two years to capture ongoing innovation driven by second-gen product development.

White Space Analysis and R&D Guidance for $120 Million Product Area

Guided R&D activities for $120 million product area for public life sciences company by analyzing patent landscape to identify white space and exclusivity opportunities.

Claim Strategy Formulation for Future Filings

Formulated claim strategies for flagship gene editing system and standardized approach for future filings at biotech startup.

Led IP Diligence Process with Series B Investors

Led IP diligence process with series B investors for biotech startup, including development of key messages on patentability and FTO.

Contact Us
  • Worldwide
  • Boston, MA
  • Denver, CO
  • Dublin, Ireland
  • Edwardsville, IL
  • Jefferson City, MO
  • Kansas City, MO
  • Las Vegas, NV
  • London, England
  • Miami, FL
  • New York, NY
  • Philadelphia, PA
  • Princeton, NJ
  • Salt Lake City, UT
  • St. Louis, MO
  • Washington, D.C.
  • Wilmington, DE
abstract image of world map
Boston, MA
800 Boylston St.
30th Floor
Boston, MA 02199
Google Maps
Boston, Massachusetts
Denver, CO
4643 S. Ulster St.
Suite 800
Denver, CO 80237
Google Maps
Denver, Colorado
Dublin, Ireland
Fitzwilliam Hall, Fitzwilliam Place
Dublin 2, Ireland
Google Maps
Edwardsville, IL
115 N. Second St.
Edwardsville, IL 62025
Google Maps
Edwardsville, Illinois
Jefferson City, MO
101 E. High St.
First Floor
Jefferson City, MO 65101
Google Maps
Jefferson City, Missouri
Kansas City, MO
2345 Grand Blvd.
Suite 1500
Kansas City, MO 64108
Google Maps
Kansas City, Missouri
Las Vegas, NV
1980 Festival Plaza Drive, Suite 750
One Summerlin
Las Vegas, NV 89135
Google Maps
Las Vegas, Nevada
London, England
Royal College of Surgeons of England
38-43 Lincoln’s Inn Fields
London, WC2A 3PE
Google Maps
Miami, FL
355 Alhambra Circle
Suite 1250
Coral Gables, FL 33134
Google Maps
Photo of Miami, Florida
New York, NY
7 Times Square, 44th Floor
New York, NY 10036
Google Maps
New York City skyline
Philadelphia, PA
2005 Market Street
29th Floor, One Commerce Square
Philadelphia, PA 19103
Google Maps
Philadelphia, Pennsylvania
Princeton, NJ
100 Overlook Center
Second Floor
Princeton, NJ 08540
Google Maps
Princeton, New Jersey
Salt Lake City, UT
201 South Main Street
Suite 750
Salt Lake City, UT 84111
Google Maps
Salt Lake City, Utah
St. Louis, MO
7700 Forsyth Blvd.
Suite 1800
St. Louis, MO 63105
Google Maps
St. Louis, Missouri
Washington, D.C.
1050 Connecticut Avenue NW
Suite 500
Washington, DC 20036
Google Maps
Photo of Washington, D.C. with the Capitol in the foreground and Washington Monument in the background.
Wilmington, DE
1007 North Market Street
Wilmington, DE 19801
Google Maps
Wilmington, Delaware